Health-related quality of life and productivity impact in haemophilia patients with inhibitors.
about
Importance of immune response genes in hemophilia APhysical and psychosocial challenges in adult hemophilia patients with inhibitors.The economics of inpatient on-demand treatment for haemophilia with high-responding inhibitors: a US retrospective data analysis.The 12-item medical outcomes study short form health survey version 2.0 (SF-12v2): a population-based validation study from Tehran, IranImmune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice.Factor VIII inhibitors in hemophilia A: rationale and latest evidenceOptimal management of hemophilic arthropathy and hematomasProphylaxis vs. on-demand treatment with Nuwiq(®) (Human-cl rhFVIII) in adults with severe haemophilia A.Novel, human cell line-derived recombinant factor VIII (Human-cl rhFVIII, Nuwiq(®) ) in children with severe haemophilia A: efficacy, safety and pharmacokinetics.Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq(®) ) in adults with severe haemophilia A: efficacy and safety.Determining the health-related quality of life in individuals with haemophilia in developing economies: results from the Brazilian population.Longitudinal changes in health-related quality of life for chronic diseases: an example in hemophilia A.Low mortality from intracranial haemorrhage in paediatric patients with haemophilia.The effect of yoga on the quality of life in the children and adolescents with haemophilia.Health-related quality of life in haemophilia patients with inhibitors and their caregivers.Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment.Rehabilitation improved walking ability for three haemophilia patients with inhibitors.Prophylaxis with anti-inhibitor coagulant complex improves health-related quality of life in haemophilia patients with inhibitors: results from FEIBA NF Prophylaxis Study.A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.Quality of life in haemophilia A: Hemophilia Utilization Group Study Va (HUGS-Va).Physician preferences for medication attributes for the prophylactic treatment of patients with severe haemophilia A with inhibitors to factor VIII.Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire
P2860
Q27025467-EBF03176-6FFC-40C7-9C90-F8DC7A9008BBQ33968730-B9F5630C-D29D-4DFD-9894-987C39D544C7Q33980524-7B71FA17-DA0C-44BB-82D5-0E0D34C96E46Q34712703-17F7EA24-4467-40BF-A649-F167E2E9A803Q37977140-702BD218-AB41-49FC-9C59-FACD9DF20305Q38101041-8E066D82-E996-4FE0-BD50-1EAD4BE7BFE7Q38266031-F827DC9E-D46F-4FE1-94B6-B5754C6C3639Q38818573-0557E74D-6B14-41BB-8DA4-3CBE9568FBDFQ38835294-2CFD0EE3-24FF-43FB-9B28-92437DED058CQ38840145-F000CCD2-ED98-4505-82F2-3DB12341E3B1Q39120920-F337A761-D3D5-478A-8331-8FCFF36D9A9AQ39159062-1F835181-63CC-4859-AC01-03F342E8C5FFQ40902649-50118BDF-B9BC-4AE4-9F06-40AC289354A8Q40905925-F453BCDB-3D62-4578-B7BB-86650CCCFBF7Q44648378-BFE7D07E-81AF-44C2-B7A8-44FC69A4CF50Q45260428-CF1EB0DC-54DE-4ABF-8587-8110C45D3BDCQ45862964-FD8E8D65-4BB6-439C-B4AE-C27671723463Q45862969-ADA1C685-E383-4B6A-9C45-9C0FCF766822Q45873374-D1BE2A5B-0A07-4793-9240-152559451019Q45878568-C9E6AFD7-4F6A-48C1-B8AF-A1D79D2FA6B7Q45882018-946E0D8C-A0FF-483F-A58B-ED99C9BCA11EQ57170226-8A5F4F98-93CB-4689-BB86-F3E88EB394DF
P2860
Health-related quality of life and productivity impact in haemophilia patients with inhibitors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Health-related quality of life ...... ilia patients with inhibitors.
@en
Health-related quality of life ...... ilia patients with inhibitors.
@nl
type
label
Health-related quality of life ...... ilia patients with inhibitors.
@en
Health-related quality of life ...... ilia patients with inhibitors.
@nl
prefLabel
Health-related quality of life ...... ilia patients with inhibitors.
@en
Health-related quality of life ...... ilia patients with inhibitors.
@nl
P2093
P1433
P1476
Health-related quality of life ...... ilia patients with inhibitors.
@en
P2093
P304
P356
10.1111/J.1365-2516.2009.02032.X
P577
2009-04-09T00:00:00Z